These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2575300)

  • 1. Membranocystic lesion in the brain in cerebrotendinous xanthomatosis. Histochemical and ultrastructural study with evidence of its ceroid nature.
    Elleder M; Michalec C; Jirásek A; Khun K; Havlová M; Ranný M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(6):367-74. PubMed ID: 2575300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. So-called membranocystic lesion (MCL)--a new variant of ceroid type lipopigment.
    Elleder M
    Adv Exp Med Biol; 1989; 266():191-206; discussion 207. PubMed ID: 2486151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary extracellular ceroid type lipopigment. A histochemical and ultrastructural study.
    Elleder M
    Histochem J; 1991 Jun; 23(6):247-58. PubMed ID: 1938471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthoma tissue-extracted LDL density substances are the main inducer of myelin-like bodies and ceroid granules in foam cells.
    Nakajima K; Ikeda M; Yagyu K; Nakajima H; Matsumoto M; Seike M; Kodama H
    Med Mol Morphol; 2007 Mar; 40(1):40-5. PubMed ID: 17384989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
    Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.
    Siebner HR; Berndt S; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):582-5. PubMed ID: 8778269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis.
    Bencze KS; Vande Polder DR; Prockop LD
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):166-7. PubMed ID: 2107278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol.
    Björkhem I; Buchmann MS; Skrede S
    Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.
    Dotti MT; Salen G; Federico A
    Dev Neurosci; 1991; 13(4-5):371-6. PubMed ID: 1817044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis and phytosterolemia].
    Nakamura T; Matsuzawa Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):794-7. PubMed ID: 3152095
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature.
    Soffer D; Benharroch D; Berginer V
    Acta Neuropathol; 1995; 90(2):213-20. PubMed ID: 7484100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrotendinous xanthomatosis and bile acids].
    Hoshita T
    Nihon Rinsho; 1984 Jul; 42(7):1664-70. PubMed ID: 6492409
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid storage disease: Part I. Ultrastructure of xanthoma cells in various xanthomatous diseases.
    Takahashi K; Naito M
    Acta Pathol Jpn; 1983 Sep; 33(5):959-77. PubMed ID: 6650173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrotendinous xanthomatosis.
    Grundy SM
    N Engl J Med; 1984 Dec; 311(26):1694-5. PubMed ID: 6504107
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
    Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
    N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.